205
Views
23
CrossRef citations to date
0
Altmetric
Review

Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)

, MS PhD
Pages 255-271 | Published online: 08 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yifeng Jin, Daulat B. Khadka & Won-Jea Cho. (2016) Pharmacological effects of berberine and its derivatives: a patent update. Expert Opinion on Therapeutic Patents 26:2, pages 229-243.
Read now
Alessia Tarditi, Andrea Caricasole & Georg Terstappen. (2009) Therapeutic targets for Alzheimer's disease. Expert Opinion on Therapeutic Targets 13:5, pages 551-567.
Read now

Articles from other publishers (20)

Manisha Singh, Vinayak Agarwal, Pranav Pancham, Shriya Agarwal, Siddhi Bhardwaj & Shalini Mani. 2022. Current Thoughts on Dementia. Current Thoughts on Dementia 417 440 .
Sadaf Dorandish, Asana Williams, Sarah Atali, Sophia Sendo, Deanna Price, Colton Thompson, Jeffrey Guthrie, Deborah Heyl & Hedeel Guy Evans. (2021) Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells. Scientific Reports 11:1.
Crossref
Sarah Atali, Sadaf Dorandish, Jonathan Devos, Asana Williams, Deanna Price, Jaylen Taylor, Jeffrey Guthrie, Deborah Heyl & Hedeel Guy Evans. (2020) Interaction of amyloid beta with humanin and acetylcholinesterase is modulated by ATP. FEBS Open Bio 10:12, pages 2805-2823.
Crossref
Deanna Price, Sadaf Dorandish, Asana Williams, Brandon Iwaniec, Alexis Stephens, Keyan Marshall, Jeffrey Guthrie, Deborah Heyl & Hedeel Guy Evans. (2020) Humanin Blocks the Aggregation of Amyloid-β Induced by Acetylcholinesterase, an Effect Abolished in the Presence of IGFBP-3. Biochemistry 59:21, pages 1981-2002.
Crossref
Md. Sahab Uddin, Md. Tanvir Kabir, Philippe Jeandet, Bijo Mathew, Ghulam Md Ashraf, Asma Perveen, May N. Bin-Jumah, Shaker A. Mousa & Mohamed M. Abdel-Daim. (2020) Novel Anti-Alzheimer’s Therapeutic Molecules Targeting Amyloid Precursor Protein Processing. Oxidative Medicine and Cellular Longevity 2020, pages 1-19.
Crossref
Ning Wang, Panpan Qiu, Wei Cui, Xiaojun Yan, Bin Zhang & Shan He. (2019) Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present). Current Medicinal Chemistry 26:30, pages 5684-5710.
Crossref
Xu-Xu Zhuang, Xuan Zang, Guang-Yao Zheng, Nan Hua, Yi Sun, Yu-Hui Hu & Ling He. (2018) Polyprenols mitigate cognitive dysfunction and neuropathology in the APP/PS1 mouse. Phytotherapy Research 32:6, pages 1098-1107.
Crossref
Cui Hao, Wei Wang, Shuyao Wang, Lijuan Zhang & Yunliang Guo. (2017) An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders. Marine Drugs 15:4, pages 89.
Crossref
A. Hall & A.I. Velter. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 280 325 .
Carlos Cardoso, Cláudia Afonso & Narcisa M. Bandarra. (2016) Dietary DHA and health: cognitive function ageing. Nutrition Research Reviews 29:2, pages 281-294.
Crossref
Yuanyuan Li, Xing Yuan, Yunheng Shen, Jing Zhao, Rongcai Yue, Fang Liu, Weiwei He, Rui Wang, Lei Shan & Weidong Zhang. (2016) Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid. Aging 8:3, pages 521-533.
Crossref
Ratih Pangestuti & Se-Kwon Kim. (2013) Marine-derived bioactive materials for neuroprotection. Food Science and Biotechnology 22:5, pages 1-12.
Crossref
Siva Sundara Kumar Durairajan, Liang-Feng Liu, Jia-Hong Lu, Lei-Lei Chen, Qiuju Yuan, Sookja K. Chung, Ling Huang, Xing-Shu Li, Jian-Dong Huang & Min Li. (2012) Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model. Neurobiology of Aging 33:12, pages 2903-2919.
Crossref
Walter J. Lukiw & Nicolas G. Bazan. (2010) Inflammatory, Apoptotic, and Survival Gene Signaling in Alzheimer’s Disease. Molecular Neurobiology 42:1, pages 10-16.
Crossref
Ratih Pangestuti & Se-Kwon Kim. (2010) Neuroprotective Properties of Chitosan and Its Derivatives. Marine Drugs 8:7, pages 2117-2128.
Crossref
Francesco Panza, Vincenzo Solfrizzi, Vincenza Frisardi, Bruno P. Imbimbo, Cristiano Capurso, Alessia D’Introno, Anna M. Colacicco, Davide Seripa, Gianluigi Vendemiale, Antonio Capurso & Alberto Pilotto. (2013) Beyond the neurotransmitter-focused approach in treating Alzheimer’s Disease: drugs targeting β-amyloid and tau protein. Aging Clinical and Experimental Research 21:6, pages 386-406.
Crossref
Francesco Panza, Vincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, Alessia DʼIntrono, Anna M. Colacicco, Gianluigi Vendemiale, Antonio Capurso & Bruno P. Imbimbo. (2009) Disease-Modifying Approach to the Treatment of Alzheimerʼs Disease. Drugs & Aging 26:7, pages 537-555.
Crossref
Clare E. Hunt & Anthony J. Turner. (2009) Cell biology, regulation and inhibition of β‐secretase (BACE‐1). The FEBS Journal 276:7, pages 1845-1859.
Crossref
Roman Sordan, Alessio Miranda, Floriano Traversi, Davide Colombo, Daniel Chrastina, Giovanni Isella, Massimo Masserini, Leo Miglio, Klaus Kern & Kannan Balasubramanian. (2009) Vertical arrays of nanofluidic channels fabricated without nanolithography. Lab on a Chip 9:11, pages 1556.
Crossref
Walter J. Lukiw & Nicolas G. Bazan. (2008) Docosahexaenoic Acid and the Aging Brain. The Journal of Nutrition 138:12, pages 2510-2514.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.